PDPeter Dolliner

Peter Dolliner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peter Dolliner has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Andreas Gleiss

    Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Guenter Steurer

    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Leopold Stiebellehner

    Division of Pneumology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Lindsay Brammen

    Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Martin Huelsmann

    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria

    1 shared publication
  • Philipp Ubl

    Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

    1 shared publication

Latest Publications

  • Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic

    by Peter Dolliner, Lindsay Brammen, Senta Graf, Martin Huelsmann, Leopold Stiebellehner, Andreas Gleiss, Philipp Ubl, Guenter Steurer

    Background Sleep disordered breathing (SDB) has important clinical implications in patients with congestive heart failure (CHF). We performed portable recording in unselected CHF patients on contemporary therapy. Data on the interactions of SDB in patients supervised at heart failure clinics are rare and we illustrate diversities of obstructive sleep apnoea (OSA) and central sleep apnoea (CSA). Methods We studied 176 consecutive subjects on contemporary medical therapy with a median left ventricular ejection fraction of 25.0 % (range 7–35 %) and median NT-pro BNP levels of 3,413.0 pg/ml (range 305.1–35,000.0 pg/ml). Participants underwent prospective overnight portable recording. Results 50 % presented with an at least moderate form of nocturnal breathing disorder [apnoea–hypopnoea index (AHI) ≥15/h]. Only 15 patients (17.1 %) with AHI ≥15/h reported excessive daytime sleepiness. Irrespective of left ventricular ejection fraction, patients with CSA had higher levels of NT-pro BNP compared to patients with OSA (differences in medians = 2,639.0 pg/ml, p = 0.016), and compared to patients with an AHI p < 0.001). OSA affected 26 patients (14.8 %). Conclusions Patients with severe stable CHF on contemporary therapy have a prevalence of 50.0 % of moderate to severe SDB. The natural cascade of the failing heart is initially characterised by absent SDB or OSA, whereas end-stage CHF is associated with CSA.